Catalyst Wire Dossier Catalyst Wire Dossier

XHANCE

Fluticasone propionate · OptiNose US, Inc.
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for XHANCE, covering 2017-09-18 to 2024-03-15. Get the full timeline:

Most recent: FDA Approved: XHANCE — Supplemental Application (OptiNose US, Inc.)

See pricing